These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 13615483)
1. [Result of use of dopan in treatment of chronic myeloleukosis]. MOKEEVA RA Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483 [No Abstract] [Full Text] [Related]
2. First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors. VISHNIAKOVA EG Vopr Onkol; 1958; 4(5):569-72. PubMed ID: 13625640 [No Abstract] [Full Text] [Related]
3. [Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis]. Levitin EI; Kukharenko IuA; Gor'kov VA; Evseenko LS Izv Akad Nauk SSSR Biol; 1973; 4():566-72. PubMed ID: 4518679 [No Abstract] [Full Text] [Related]
4. [The treatment of subleukemic myeloleukosis with Dopan]. Morozova VT; Miroshnichenko IS; Terent'eva NI Ter Arkh; 1967 Feb; 39(2):19-20. PubMed ID: 5611685 [No Abstract] [Full Text] [Related]
5. [New method of treating patients with rheumatoid arthritis using electrophoresis of the immunosuppressive preparation dopan from a dimexide solution]. Kozlova LA; Tereshina LG Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (1):33-5. PubMed ID: 3518232 [No Abstract] [Full Text] [Related]
6. [A case of chronic myelogenous leucaemia treated with nitrogen mustard N-oxide]. KUROYANAGI S Gan; 1953 Sep; 44(2-3):397-8. PubMed ID: 13128215 [No Abstract] [Full Text] [Related]
7. [Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas]. VESIN S Cas Lek Cesk; 1952 Nov; 91(45-46):1384-7. PubMed ID: 14390440 [No Abstract] [Full Text] [Related]
8. [THE USE OF DOPAN AND MYELOSAN IN THE TREATMENT OF PATIENTS WITH CHRONIC MYELOLEUKEMIA]. SPASSKII OV Sov Med; 1963 May; 26():30-3. PubMed ID: 14073326 [No Abstract] [Full Text] [Related]
9. [The use of Dopan in the treatment of pigmentary degeneration of the retina and atrophy of the optic nerve]. Frantseva IA Oftalmol Zh; 1968; 23(2):145. PubMed ID: 5733328 [No Abstract] [Full Text] [Related]
10. [The use of dopan in thrombosis of the central vein of the retina]. Kartasheva EA Vestn Oftalmol; 1967; 80(3):25-7. PubMed ID: 5615713 [No Abstract] [Full Text] [Related]
12. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology]. Sikorskaia IaV Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039 [No Abstract] [Full Text] [Related]
13. [Preliminary data on application of dopamine lymphogranulomatosis]. IVANOVA EM Vopr Onkol; 1957; 3(5):556-62. PubMed ID: 13507321 [No Abstract] [Full Text] [Related]
14. [Experiences with clinical use of some new chemotherapeutics in tumor therapy]. PEREVODCHIKOVA NJ Dtsch Med Wochenschr; 1958 Jan; 83(1):21-3. PubMed ID: 13500993 [No Abstract] [Full Text] [Related]
15. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan]. Mal'tseva LF Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367 [No Abstract] [Full Text] [Related]